Your browser doesn't support javascript.
loading
Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes.
Frampton, Jennifer; Kearney, Kathleen E; Abbott, J Dawn; Kereiakes, Dean J; Di Mario, Carlo; Saito, Shigeru; Cristea, Ecaterina; Riley, Robert F; Fajadet, Jean; Shlofmitz, Richard A; Ali, Ziad A; Klein, Andrew J; Price, Matthew J; Hill, Jonathan M; Stone, Gregg W; Lansky, Alexandra J.
Afiliação
  • Frampton J; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Kearney KE; University of Washington, Seattle, Washington.
  • Abbott JD; Lifespan Cardiovascular Institute and Warren Alpert Medical School of Brown University, Providence, Rhode Island.
  • Kereiakes DJ; The Christ Hospital and the Lindner Research Center, Cincinnati, Ohio.
  • Di Mario C; Careggi University Hospital, Florence, Italy.
  • Saito S; Shonan-Kamakura General Hospital, Kamakura, Kanagawa, Japan.
  • Cristea E; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Riley RF; Overlake Medical Center & Clinics, Bellevue, Washington.
  • Fajadet J; Clinique Pasteur, Toulouse, France.
  • Shlofmitz RA; St. Francis Hospital, Roslyn, New York.
  • Ali ZA; Cardiovascular Research Foundation, New York, New York.
  • Klein AJ; Piedmont Heart Interventional Cardiology, Atlanta, Georgia.
  • Price MJ; Scripps Clinic, La Jolla, California.
  • Hill JM; Royal Brompton Hospital, London, United Kingdom.
  • Stone GW; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Lansky AJ; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
J Soc Cardiovasc Angiogr Interv ; 2(6Part A): 101069, 2023.
Article em En | MEDLINE | ID: mdl-39129889
ABSTRACT

Background:

Intravascular lithotripsy (IVL) for calcified lesion preparation prior to drug-eluting stent placement has high procedural success and safety, especially in women, whereas other atheroablative approaches are associated with increased procedural complications. We sought to investigate long-term sex-based outcomes of IVL-facilitated stenting.

Methods:

We performed a patient-level pooled analysis of the single-arm Disrupt CAD III and IV studies. Patient baseline, procedural characteristics, and outcomes were examined according to sex at 30 days and 1 year. The primary end point was major adverse cardiac events (a composite of cardiac death, all myocardial infarction, or target vessel revascularization). Target lesion failure was defined as cardiac death, target vessel myocardial infarction, or ischemia-driven target lesion revascularization.

Results:

A total of 448 patients, 106 (24%) women, were included. Women were older and less likely to be smokers. Women had smaller reference vessel diameters (2.8 mm vs 3.1 mm), shorter lesion length (23.6 mm vs 27.1 mm), and shorter total calcified length (44.4 mm vs 49.3 mm) compared with men. Post-IVL angiographic outcomes and complications were similar between women and men. At 1 year, major adverse cardiac event rates (12.3% vs 13.2%, P = .52) were not different between women and men. There were no differences between women and men (10.4% vs 11.2%; P = .43) in target lesion failure at 1 year.

Conclusions:

Use of IVL in the treatment of severely calcified lesions is associated with low rates of adverse clinical events and with similar safety and effectiveness in women and men at 1 year.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article